Local Anesthesia
Local Anesthetic Drug Lidocaine Base CAS 137-58-6
product description
Introducing our high-quality local anesthetic drug, Lidocaine Base CAS 137-58-6, a powerful and effective solution for pain relief. Lidocaine Base is a widely used medication that acts as a numbing agent, making it an essential component in various medical and cosmetic procedures.
Our Lidocaine Base is formulated with the highest standards of quality and purity, ensuring its safety and efficacy for a wide range of applications. Whether it’s used for minor surgical procedures, dental work, or as a topical anesthetic for skin conditions, our product delivers reliable and consistent results.
One of the key advantages of Lidocaine Base is its rapid onset of action, providing quick relief from discomfort and pain. This makes it an invaluable tool for healthcare professionals and patients alike, allowing for a more comfortable and pain-free experience during medical procedures.
What is lidocaine?
Lidocaine acts as a local anesthetic by reversibly blocking sodium channels and blocking the transmission of action potentials along nerve fibers. Sensory fibers are blocked earlier than motor fibers, so low doses of lidocaine can act as a selective sensory block. Lidocaine also has antiarrhythmic effects, belonging to class I and b antiarrhythmic drugs.
Lidocaine is an Anesthetic (local); antiarrhythmic (class IB). Long-acting, membrane stabilizing agent against ventricular arrhythmia. Originally developed as a local anesthetic. Neuroprotective & Neuroresearch Products. Lidocaine is widely used in surface anesthesia, anesthesia, conduction anesthesia and epidural anesthesia. The LD50 of oral lidocaine hydrochloride to mice was 290 mg/kg.
Function
Lidocaine is suitable for acute ventricular arrhythmias, including premature ventricular beats, ventricular tachycardia, and ventricular fibrillation, caused by acute myocardial infarction, surgery, digitalism, and cardiac catheterization. Secondly, it is also used for epileptic status.
Application
Lidocaine is the first-line agent for the treatment of ventricular arrhythmias caused by acute and severe hemodynamic abnormalities. It is also effective for some supraventricular arrhythmias, such as bypass mediated supraventricular tachycardia, and acute episodes or parasympathetic mediated cardioversion of atrial fibrillation. It is widely used for surface anesthesia of mucous membranes (e.g. before endotracheal intubation). EMLA cream is used to anesthetize the skin surface before intravenous catheterization. To ensure the anesthetic effect, apply it to the skin for 45 to 60 minutes, and wrap it with an airtight dressing to promote absorption. EMLA is very useful for ear vein catheterization in rabbits and for intravenous catheterization in young dogs and cats.
details
